Side-of-Building2.jpg

ABOUT

Jeff.PNG

Jeffrey I. Auerbach

The founder and managing member of Auerbach, LLC, a Rockville, Maryland, intellectual property law firm.

Dr. Auerbach received his B.S. degree in biochemistry, genetics, and microbiology from Cornell University in 1975.  He received his M.Phil. and Ph.D. degrees in molecular biophysics and biochemistry from Yale University in 1977 and 1981, respectively.  Before entering into a career in patent law, Dr. Auerbach served as a research scientist at the Laboratory of Molecular Biology of the National Cancer Institute, at W.R. Grace & Company, and at SmithKline & French Laboratories (where he received that company’s highest research award).  Dr. Auerbach also served as an Examiner of immunology patents for the U.S. Patent & Trademark Office.  He began his career in patent law in 1985 and received his J.D. degree in 1989, from the National Law Center of George Washington University.  Prior to forming Auerbach, LLC, Dr. Auerbach was an associate at Weil, Gotshal & Manges, and a partner at Howrey, LLP.

Dr. Auerbach’s practice focuses on the preparation and prosecution of patent applications relating to molecular biology, genetics, microbiology, therapeutics, diagnostics, bioinformatics, on strategic counseling and on the enforcement and exploitation of global patent rights.  His background in biophysics has, however, permitted him to work in a broad array of different technologies, including computer architecture, material sciences, polymer chemistry, software and telecommunication protocols.  Dr. Auerbach’s clients have ranged from multinational corporations such as Genentech, Inc., H. Lundbeck A/S, DiaSorin S.p.A., The Monsanto Company, Boehringer Ingelheim GmbH, and Baidu, Inc., to younger companies and major academic and research institutions, such as MacroGenics, Inc., the US National Institutes of Health, the University of Maryland, New York University, Yale University, Princeton University, the University of Oxford, Hiroshima University and the University of Tokyo.  Dr. Auerbach has significant experience in patent licensing, trade secret law and patent litigation having served as counsel in some of the most complex biotechnology licensing, trade secret and patent disputes to have arisen in the past 35 years.

Dr. Auerbach is also an inventor, having received patents in the United States and throughout the world for his inventions in vaccine production, and isothermal “rolling circle” nucleic acid amplification.  In 1994, he founded Replicon, Inc., a Maryland biotechnology company focused on the use of rolling circle amplification in diagnostics, genomics and therapeutics, and served as its president until its 2003 acquisition by Biokit S.A.  Dr. Auerbach is a philanthropist and has served as a member of the Washington, DC Board of the American Committee for the Weizmann Institute of Science, and as a Diplomat of that Institute, and as a Director of the International Biomedical Research Alliance.

Dr. Auerbach is a member of the bars of Maryland, Virginia, New York and the District of Columbia.  He is also a member of the bars of the U.S. District Courts for the Districts of Maryland and District of Columbia Circuits, and of the U.S. Courts of Appeals for the District of Columbia and Federal Circuits.  He is registered to practice before the U.S. Patent and Trademark Office.  Dr. Auerbach has served as an adjunct faculty member of the Johns Hopkins University, teaching courses in biotechnology law.  He is the author of many publications, including the web monograph “Patent Law Principles and Strategies.”  Dr. Auerbach’s biography has appeared in “Marquis® Who’s Who in American Law” and “Marquis® Who’s Who in America.”  He is nationally peer-rated by Martindale-Hubbell / Reed Elsevier Properties, Inc.

dots-6297146_1920.jpg